PET tracers and radiochemistry.
This paper provides a brief review of the radiochemistry of radiopharmaceuticals used in positron emission tomography (PET). It includes some history of PET, the basic formation of radionuclides in a cyclotron target, the processing of the precursor molecules into a useful PET radiotracer and the clinical significance and outlook for PET radiotracers. This review is based on a series of recent books and articles outlining the fundamental goals of PET and how radiochemistry plays a part in achieving these goals. It is also drawn from the literature that has been developed in PET over the last 30 years since PET became a research and valuable clinical tool. PET is a growing field and the clinical applications of the chemistry and technology have just begun to be explored. There is a great deal left to do in order to explore the full potential of PET in the clinic.
Schlyer
D J
DJ
Chemistry Department, Brookhaven National Laboratory, Upton, NY 11973, USA.
D006331:Heart Diseases / Q000000981:diagnostic imaging; D006801:Humans; D009369:Neoplasms / Q000000981:diagnostic imaging / Q000532:radiotherapy; D011849:Radioactive Tracers; D019275:Radiopharmaceuticals / Q000138:chemical synthesis* / Q000627:therapeutic use; D014055:Tomography, Emission-Computed
D011849:Radioactive Tracers; D019275:Radiopharmaceuticals